|

Oral or short-acting granulocyte-stimulating agents Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Affiliated Hospital of Nantong University1

Indications

  • Myelosuppression1
  • Thoracic Neoplasms1
  • Chemoradiotherapy1
  • Cancer1

Other1 trial

Clinical Study of Thiopegfilgrastim for Preventing Bone Marrow Suppression in Thoracic Tumor Chemoradiotherapy
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.